drugset / Trial / NCT03228862

Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults

NCT03228862

Phase 4 Unknown 360 enrolled Chulalongkorn University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate the optimal initial and maintenance doses of vitamin D2 supplementation for the treatment of vitamin D insufficiency in Thai adults, and to determine the prevalence of and risk factors for hypovitaminosis D among Thai adults.

Timeline

Start
2017-05-01
Primary completion
2018-02-01
Completion
2018-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferol Small molecule 20000 iu
Subject Ergocalciferol Small molecule 40000 iu
Subject Ergocalciferol Small molecule 60000 iu
Subject Ergocalciferol Small molecule 80000 iu

Indications